|
|
Volumn 30, Issue 4, 2002, Pages 507-511
|
|
Bispecific antibodies targeting cancer cells
|
|
Author keywords
Fc receptor; Immunotherapy; Recombinant
|
|
Indexed keywords
ANTIGEN;
BISPECIFIC ANTIBODY;
CD16 ANTIGEN;
CD64 ANTIGEN;
CD89 ANTIGEN;
FC RECEPTOR;
GAMMA INTERFERON;
GRANULOCYTE COLONY STIMULATING FACTOR;
IMMUNOGLOBULIN F(AB) FRAGMENT;
IMMUNOGLOBULIN G;
IMMUNOGLOBULIN G1;
RECEPTOR SUBTYPE;
RECOMBINANT ANTIBODY;
TRASTUZUMAB;
TUMOR ANTIGEN;
UNCLASSIFIED DRUG;
ANTIBODY ENGINEERING;
ANTIBODY PRODUCTION;
ANTIBODY SPECIFICITY;
ANTIBODY STRUCTURE;
CANCER CELL;
CANCER IMMUNOTHERAPY;
CELL ACTIVATION;
CLINICAL TRIAL;
CONFERENCE PAPER;
CYTOTOXICITY;
DRUG EFFICACY;
DRUG MECHANISM;
EFFECTOR CELL;
EXPRESSION VECTOR;
HUMAN;
IN VITRO STUDY;
IN VIVO STUDY;
INSECT CELL;
KILLER CELL;
MAMMAL CELL;
NONHUMAN;
PLASMA HALF LIFE;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN PROTEIN INTERACTION;
TARGET CELL;
YEAST;
ANTIBODIES, BISPECIFIC;
HUMANS;
IMMUNOGLOBULIN G;
IMMUNOTHERAPY;
MODELS, MOLECULAR;
NEOPLASMS;
PROTEIN CONFORMATION;
RECEPTORS, FC;
RECOMBINANT PROTEINS;
ANIMALIA;
INSECTA;
MAMMALIA;
VECTORS;
|
|
EID: 0036671332
PISSN: 03005127
EISSN: None
Source Type: Journal
DOI: 10.1042/BST0300507 Document Type: Conference Paper |
|
Times cited : (54)
|
|
References (46)
|
